fda glp-1 warning letters news warns against compounded medications Last month, the FDA issued

The study involved over 7000 ischemic stroke survivors, showing a 74% lower death risk and 84% lower heart attack risk with these medications

However, the safety of this adjustment depends entirely on the gap between your last shot and the new one

Unlike the other weight loss injections, that are GLP-1 receptor agonists, it has a powerful double action, being a GLP-1 and GIP receptor agonist." Dorianne Green, Medical Writer Clinical studies highlight impressive results: average weight losses of 15% at 5 mg, 19% at 10 mg, and 21% at 15 mg

The Congressional Budget Office (CBO) has stated, "The developing market for [anti-obesity medications] could significantly affect health care spending and the federal budget." They contend that passage of the Treat and Reduce Obesity Act would increase costs for anti-obesity medications (i.e., because more people would use them) but reduce federal costs for other related health issues